Qifeng Yu

Also affiliated with Shenzhen University

Computer ScienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial”.

Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

The Lancet. Gastroenterology & hepatology(2024)10.1016/s2468-1253(24)00074-8

N/A

1.0DataRank · unranked

42 citations

Madeleine Aumar, Alastair Baker, Ulrich Baumann, Philip Bufler, Mara Cananzi +22 more